Lilly gains critical patient insights with Temedica’s Permea Disease Navigator and Services

70% of product candidates that fail to meet expectations at launch, continue to miss them in subsequent years - meaning a poorly executed launch can ultimately lead to the failure of a product.
With limited budgets, personnel, and time, commercial teams must have a data-driven, go-to-market plan and compliant technology to drive them to success.
In this whitepaper, you will learn how to use data-driven insights to empower your commercial team with a 360° patient view to: